Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Inflammatory bowel disease (IBD) patients are at increased risk for venous thromboembolism
(VTE) compared to the general population. Practice guidelines recommend pharmacologic
prophylaxis for IBD inpatients.
[1
]
Penn State Hershey Inflammatory Bowel Disease Center, Penn State College of Medicine,
Hershey, PA, United States; Division of Gastroenterology and Hepatology, Penn State
Hershey Medical Center, Hershey, PA, United States. Electronic address: atinsley@hmc.psu.edu.